New Key Statistics Module, Z-Score and F-Score
OTCPK:AGRX Key Ratios
| Market Cap $ M | 2.59 |
| Enterprise Value $ M | 2.21 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.04 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 19.00 |
| EPS (TTM) $ | -9.74 |
| Beneish M-Score | -8.19 |
| 10-y EBITDA Growth Rate % | 37.00 |
| 5-y EBITDA Growth Rate % | 61.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.17 |
| EV-to-EBITDA | -0.17 |
| PEG | -- |
| Shares Outstanding M | 6.86 |
| Net Margin (%) | -73.85 |
| Operating Margin % | -101.50 |
| Pre-tax Margin (%) | -73.85 |
| Quick Ratio | 0.33 |
| Current Ratio | 0.46 |
| ROA % (ttm) | -117.33 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -372.84 |
| Dividend Yield % | -- |
| Altman Z-Score | -61.32 |
AGRX Number of Guru Trades
AGRX Volume of Guru Trades
Gurus Latest Trades with OTCPK:AGRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AGRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Agile Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:AGRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers